Open application window

Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) (U24 Clinical Trial Not Allowed) deadline 2026

The current listed application deadline is July 9, 2026. Use this page to verify timing fast, then move into the full grant record for planning, comparison, and drafting.

Agency
National Institutes of Health
Award range
Up to $4,000,000
Total funding
$6,000,000
Funding instrument
Cooperative Agreement
CFDA / ALN
93.121, 93.846, 93.867
Cost share
No

Application Countdown

59
Days
11
Hours
45
Minutes

Use this page as the fast check for timing, then jump into the full grant record for filters, drafting, and comparison.

Quick facts

Opportunity number
Not listed
Last updated
May 3, 2026
Expected awards
Not listed

Deadline summary

This Notice of Funding Opportunity (NOFO) solicits cooperative agreement research applications to support a multidisciplinary program titled "Accelerating Product Excellence in Innovation and for Clinical Adoption" (APEx), that will facilitate advancement of promising strategies and products for tissue engineering and regenerative medicine (TE/RM). APEx will be composed of Resource Centers (RCs) and associated Interdisciplinary Translational Projects (ITPs) in the area of therapeutics...

Key dates

Posted
May 3, 2026
Deadline
July 9, 2026

Before you apply

Confirm the official submission path and any portal requirements.
Review the close date carefully and account for agency timezone handling.
Validate fit against the listed eligibility groups before investing drafting time.
Compare adjacent opportunities if this deadline window feels too narrow.

Eligibility snapshot

State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher education

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.